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Background: The extent of surgical scarring in Tetralogy of Fallot (TOF) may be a marker of adverse outcomes and
provide substrate for ventricular arrhythmia. In this study we evaluate the feasibility of high resolution three
dimensional (3D) late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) for volumetric scar
quantification in patients with surgically corrected TOF.
Methods: Fifteen consecutive patients underwent 3D LGE imaging with 3 Tesla CMR using a whole-heart,
respiratory-navigated technique. A novel, signal-histogram based segmentation technique was tested for the
quantification and modeling of surgical scar. Total scar volume was compared to the gold standard manual expert
segmentation. The feasibility of segmented scar fusion to matched coronary CMR data for volumetric display was
explored.
Results: Image quality sufficient for 3D scar segmentation was acquired in fourteen patients. Mean patient age
was 32.2 ± 11.9 years (range 21 to 57 years) with mean right ventricle (RV) ejection fraction (EF) of 53.9 ± 9.2%
and mean RV end diastolic volume of 117.0 ± 41.5 mL/m2. The mean total scar volume was 11.1 ± 8.2 mL using
semi-automated 3D segmentation with excellent correlation to manual expert segmentation (r = 0.99, bias = 0.89 mL,
95% CI -1.66 to 3.44). The mean segmentation time was significantly reduced using the novel semi-automated
segmentation technique (10.1 ± 2.6 versus 45.8 ± 12.6 minutes). Excellent intra-observer and good inter-observer
reproducibility was observed.
Conclusion: 3D high resolution LGE imaging with semi-automated scar segmentation is clinically feasible among
patients with surgically corrected TOF and shows excellent accuracy and reproducibility. This approach may offer a
valuable clinical tool for risk prediction and procedural planning among this growing population.
Keywords: Tetrology of Fallot, Cardiovascular MR, Scar, 3D, Late gadolinium enhancement, Congenital heart diseaseBackground
Tetralogy of Fallot (TOF) is a cyanotic congenital heart
defect affecting approximately 1 in 3,600 live born in-
fants [1]. Characteristic features include a perimembra-
nous ventricular septal defect (VSD) and a varying
degree of infundibular stenosis that require surgical* Correspondence: jawhit@ucalgary.ca
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unless otherwise stated.correction early in life. However, such interventions are
inherently associated with some degree of iatrogenic scar
that contribute to regional aneurysmal dilation, systolic
dysfunction and offer substrate for the development of
ventricular arrhythmia [2,3]. While markers of future
cardiovascular events such as the severity of pulmonic
insufficiency [4] have been explored, the extent of initial
surgical disruption and scar burden may be a valuable
prognosticator [5]. Given the increasing incidence of pa-
tients with surgically corrected congenital heart disease
[6], the development and validation of tools aimed attd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Stirrat et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:76 Page 2 of 11
http://jcmr-online.com/content/16/1/76spatially characterizing and quantifying myocardial scar
in this population are of clinical importance.
Cardiovascular magnetic resonance (CMR) is an estab-
lished and preferred imaging modality for the evaluation
of patients with congenital heart disease [7]. However,
the potential value of late gadolinium enhancement
(LGE) imaging to characterize the effect of surgical dis-
ruption has only recently been explored among patients
with TOF [5,8-10]. The literature demonstrates the cap-
acity of this technique to identify surgical scarring of the
right ventricle (RV) and interventricular septum using con-
ventional, two dimensional (2D) LGE techniques. Volu-
metric quantification of this scar has proved particularly
challenging however, due to its thin and complex architec-
ture. As potential exists for scar segmentation to function
as both a prognostic tool [11-13] and therapeutic roadmap
[14] for arrhythmia ablation, its translation to this patient
population is of clinical interest. To date, such efforts
have been limited to subjective visual scoring of scar
distribution.
Here we test the feasibility of high resolution, isotropic
3D LGE CMR imaging for the characterization of surgi-
cal scar in patients with surgically corrected TOF. In
addition, we describe a novel segmentation technique
for rapid image processing and volumetric modeling.
Methods
Subjects and CMR acquisition
Fifteen consecutively identified patients with surgically
corrected TOF were recruited from an outpatient adult
congenital heart disease clinic. Patients were required to
be ≥18 years of age and have no contraindications to
contrast-enhanced CMR, inclusive of a glomerular filtra-
tion rate ≤45 ml/min/1.73 m2. All patients provided
written informed consent and the study was approved
by the Research Ethics Board of Western University.
Imaging was performed using a 3-Tesla CMR scanner
(TRIO, Siemens Medical Systems, Erlangen, Germany)
equipped with a 32-element body surface receiver coil.
The imaging protocol was composed of four sequential
procedures; Cine imaging, 3D contrast enhanced mag-
netic resonance angiography (MRA), standard 2D LGE
imaging (10 minutes post contrast administration),
followed by 3D LGE imaging (20-25 minutes post con-
trast administration). Cine images were acquired using a
steady-state free precession based pulse sequence in ser-
ial short-axis slices from the atrioventricular annulus to
the apex at 10-mm intervals, as well as in long-axis ori-
entations (slice thickness 6 mm, gap 4 mm, echo time
1.5 ms, repetition time 3.0 ms, flip angle 50°). A 3D
whole heart, inversion recovery gradient echo pulse se-
quence with a respiratory navigator pulse placed over
the right hemidiaphragm was used to obtain both an
early (coronary enhanced) and late (scar enhanced)dataset, as previously described by our group [15]. Typical
imaging parameters were: echo time 1.3 ms; flip angle 20°;
integrated parallel acquisition technique 2, end-expiratory
respiratory navigator acceptance window 3.5 mm, phase
encoding direction anterior posterior. The voxel size was
maintained at 1.3 × 1.3 × 1.3 mm (interpolation to
0.65 mm for reconstruction) in all subjects fat saturation
was employed to suppress pericardial fat signal. Imaging
volumes were prescribed in the transverse plane (anterior-
posterior phase encoding direction) from above the aortic
arch to below the most inferior aspect of the heart (slab
thickness 140-160 slices) based on multiplanar scout im-
ages. Adjustment of trigger delay and segment number
was performed to maintain image acquisition between the
onset and termination of cardiac standstill, as determined
from the 4-chamber cine. The prescribed segment num-
ber ranged from 35 to 45 per cycle, corresponding to ac-
quisition windows of 110 to 150 msec.
For the contrast-enhanced MRA, an intravenous infu-
sion of 0.2 mmol/kg gadolinium (Gadovist®, Bayer Inc.,
Toronto, Ontario, Canada) was administered at 0.3 ml/s,
followed by 40 ml of saline at the same rate. Imaging
was initiated 20 seconds following infusion onset, as pre-
viously described [16].
Standard 2D LGE was performed 10 minutes following
infusion completion using an inversion-recovery gradient
echo pulse sequence in sequential short axis imaging from
a slice location cranial to the pulmonary valve through to
the apex, in standard LV long axis views, and using an RV
inflow-outflow view. Typical imaging parameters; 8 mm
slice thickness, 2 mm gap, 1.6 × 1.3 mm in-plane
resolution.
Finally, a delayed (scar enhanced) 3D LGE dataset was
acquired 20 to 25 min following infusion completion
using adjustment of the inversion time (TI) to provide
optimal myocardial signal suppression (typical range 240
to 270 ms), as previously described [17].CMR image interpretation
Serial short-axis cine images were evaluated using semi-
automated commercially available software (CMR42, Cir-
cle International, Calgary, Alberta, Canada) to obtain
end-diastolic and end-systolic volumes of the left and
right ventricles. For both ventricles, a long-axis view was
cross-referenced to determine the basal inclusion of vol-
umes throughout the cardiac cycle, inclusive of the out-
flow tracts. Papillary and trabecular muscle architecture
were excluded from the blood pool for volumetric ana-
lysis. Contrast-enhanced MRA and matched scar-enhanced
datasets were visually scored for image quality and inter-
pretability using a 5-point scale, as follows; 0 = uninterpre-
table, 1 = unacceptable due to artifact, 2 = acceptable with
artifact, 3 = good, 4 = excellent.
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the presence or absence of RV outflow tract and septal
patch related scar (Figure 1). Volumetric scar segmenta-
tion of conventional 2D scar-enhanced datasets was per-
formed using manual planimetry. This approach was
required as manual border tracing (required for
threshold-based analysis) was found to be inaccurate
and frequently contaminated by inclusion of epicardial
fat and/or blood pool, due to the thin and complex RV
architecture. Importantly, phase reconstructed 2D LGE
images were used for this analysis as (in our clinical ex-
perience) this provides improved visualization of scar
within the RV wall. For 3D LGE scar segmentation, a
novel, semi-automated software that employs a Hier-
archical Max Flow algorithm was employed, as previ-
ously described [18]. This method uses a brush tool to
obtain a single sampling of four distinct regions
(Figure 2); normal myocardium, blood pool, scar and
background. Signal-intensity histograms from these re-
spective regions are used to classify all remaining voxels
into one of these categories using a probabilistic ap-
proach, as described by Rajchl et al. [19,20]. This algo-
rithm employs a region-ordering constraint that exploits
prior knowledge of rudimentary cardiovascular anatomy.
This avoids the need for manual boundary identification,
and largely eliminates the need for manual correction
of segmented data. The time duration for computer-
assisted segmentations (CAS) was recorded for all 3D
image datasets.
To facilitate accuracy in the assessment of the semi-
automated scar segmentation technique, as well as to pro-
vide a benchmark for segmentation efficiency, all datasets
were manually segmented by a CMR expert blinded to pa-
tient information (JAW). This was performed by manual
brush tool labeling of enhanced voxels using an identical
3D multiplanar reconstruction (MPR) interface, withFigure 1 Comparison between (left) 2-dimensional late gadolinium en
and (right) corresponding high-resolution 3D LGE imaging (voxel size 1
of Fallot. White arrows indicate region of surgical infundibulotomy scar wi
using 3D LGE imaging. Yellow arrows indicate inferior RV insertion site fibrotime required for segmentation noted again. This was
chosen as the best available gold standard. CAS-based
and gold standard manual segmentation total scar vol-
umes were compared for both accuracy and image-
processing time (efficiency). In addition, an agreement
evaluation for the spatial accuracy of voxel labeling (scar
versus not scar) was performed using standardized ac-
curacy metrics commonly reported for segmentation val-
idation. The Dice Similarity Coefficient was used to
express the percentage of all voxels assigned the same
binary value, and the average Root-Mean squared Sur-
face Error (RMSE) was used to express the average Eu-
clidean distance between the two generated surfaces.
Finally, CAS-based scar segmentation results were fused
to the spatially matched 3D contrast-enhanced MRA data-
sets (inherently spatially co-registered) for volumetric pres-
entation using an interactive 3D volume rendered display
(OsiriX, Version 4.1.2), as shown in Figure 2D.
Intra- and inter-observer reproducibility
Two blinded interpreters (J.S. and M.R.) performed CAS-
based scar segmentation on all 3D scar-enhanced datasets
to determine both intra- and inter-observer reproducibility
of this technique for the measurement of total scar volume.
Both users also performed manual planimetry on all 2D
LGE datasets to calculate the intra- and inter-observer
variability of this conventional technique.
Statistical analysis
Data are expressed as mean values ± standard deviation.
Comparisons of continuous variables (segmentation time)
were performed by means of a 2-tailed t-test, as indicated
in the Results section. A p-value ≤0.05 was considered sig-
nificant. Linear regression and Bland-Altman analyses
were performed to determine the correlation and differ-
ence in measured scar volume between CAS and manualhancement (LGE) imaging (typical voxel size 2.9 × 1.9 × 6 mm)
.3 × 1.3 × 1.3 mm) in a patient with surgically corrected Tetralogy
th improved characterization of the thin surgical scar being apparent
sis.
Figure 2 Semi-automated scar segmentation algorithm using custom software. (A) Raw image dataset of 3D-LGE shown in the axial plane
at the level of the right ventricular outflow tract. (B) A brush stroke label is applied over a region of scar (yellow), blood pool (red), myocardium
(blue), and the background tissue (gray). (C) 3D scar segmentation results shown in a volume-rendered format. Infundibulotomy and septal patch
scar are both clearly visible. (D) Final fused 3D-Cardiac MRA/Scar image shown in volume-rendered format.
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ity. Statistical analyses were performed using a commer-
cially available software program (GraphPad Prism,
Version 6.0, GraphPad Software, San Diego, California).
Results
Baseline characteristics
Baseline clinical characteristics are shown in Table 1. The
mean age was 32.2 ± 11.9 years (range 21 to 57 years), and
eight patients (57%) were female. The average time from
TOF surgical repair was 30.3 ± 11.9 years (range 17 to
49 years).
Baseline CMR characteristics are listed in Table 2.
The mean left ventricular ejection fraction (LVEF) was
63.7 ± 8.0%, and the mean right ventricular ejection
fraction (RVEF) was 53.9 ± 9.2%. The mean RV end dia-
stolic volume (EDV), indexed to body surface area, was
117.2 ± 40.0 mL/m2.
Three dimensional contrast-enhanced and scar-enhanced
image datasets were obtained in all 15 patients with mean
heart rate during image acquisition determined to be 68 ± 8
(range 56 to 85) beats/min. All patients were in sinus
rhythm at the time of image acquisition. Acquisitions
ranged from 649 ± 72 cardiac cycles with corresponding
mean image acquisition times of 7.1 ± 1.4 mins for coronary
MRA and 7.2 ± 1.6 mins for LGE. Combined image quality
was scored as acceptable (quality score ≥ 2 out of 4) in 14
of 15 patients (93%). The number of patients with qualityscores of 1, 2, 3, and 4 were N = 0, 1, 4, and 10 respectively
for the 3D MRA, and N= 1, 2, 6, and 5 for the 3D LGE
datasets, respectively. One patient exhibited severe motion-
related artifacts on the scar-enhanced data acquisition due
to coughing and this data was therefore excluded due to an
inability to perform analysis.
3D contrast-enhanced and scar-enhanced imaging
The mean image acquisition times for contrast-enhanced
and scar-enhanced datasets were 7.9 ± 2.6 and 7.1 ± 2.5 mi-
nutes, respectively. Mean quality scores were 3.6 ± 0.6, and
3.2 ± 0.7 out of 4, respectively. The quality scores of the ex-
cluded patient were 4 and 1 out of 4, respectively, as the
patient coughed throughout scar-enhanced acquisition.
Visual analysis of 3D scar-enhanced datasets showed
clear evidence of myocardial scar in the right ventricular
outflow tract (RVOT) (infundibulotomy site) of all 14
patients (100%), and of the basal interventricular septum
(VSD repair site) in 12 of 14 patients (86%). Typical case
examples are provided in Figure 3. Corresponding 2D
LGE image scoring showed clear evidence of RVOT scar
in 12/14 patients (86%) and basal septal scar in 3/14 pa-
tients (21%). In contrast, non-ischemic fibrosis of the RV
insertion site was scored as present in 6/14 patients
(43%) on 3D LGE, and 11/14 patients (79%) on 2D LGE
imaging. This latter pattern of LGE, when visualized, was
excluded from 3D segmentation for two reasons; i) signal
histograms of surgical (dense) scar were found to be unique
Table 1 Non-CMR baseline patient characteristics,
presented for the total population
Variable Total cohort
Age (years) 32.2 ± 11.9
Female sex 8 (57%)
Caucasian 14 (100%)
Systolic BP (mmHg) 120.1 ± 13.9
Diastolic BP (mmHg) 76.3 ± 8.1
Heart rate (beats/min) 68.7 ± 9.6




QRS duration (msec) 138.3 ± 28.2
Years since surgery 30.3 ± 11.9
NYHA class
Class I 12 (86%)
Class II 2 (14%)
Medications





Continuous data are expressed as mean ± SD, categorical data as n MI =Myocardial
infarction, GFR =Glomerular Filtration Rate; LBBB, left bundle-branch block;
NYHA=New York Heart Association; ICD= Implantable cardiac defibrillator,
CRT = Cardiac resynchronization therapy; ACE = angiotensin-converting enzyme;
ATII = angiotensin II.
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ate initialization for signal profile based segmentation, and
ii) the primary aim of the study was to evaluate method-
ology for surgical scar quantification and modeling, in par-
ticular towards its translation for image-guided therapies,
such as the ablation of scar re-entry tachyarrhythmia.Table 2 CMR parameters presented for total population
Variable Total cohort
Chamber volumes
RV EF (%) 53.9 ± 9.2
RV ESVi (mL/m2) 55.2 ± 26.3
RV EDVi (mL/m2) 117.0 ± 41.5
LV EF (%) 63.7 ± 8.0
LV ESVi (mL/m2) 25.1 ± 10.5
LV EDVi (mL/m2) 68.6 ± 21.9
Scar quantification (3D CAS)
Total scar volume (ml) 11.1 ± 8.2
Continuous data are expressed as mean ± SD. RV = Right ventricle;
EF = Ejection fraction, ESVi = End-diastolic volume index, EDVi = End-systolic
volume index, LV = Left ventricle, CAS = Computer Assisted Segmentation.3D scar segmentation and image fusion
3D scar segmentation was successfully performed in all 14
patients using both CAS and manual expert segmentation.
Total segmentation time (from initiation of image file up-
load to satisfactory generation of a final 3D segmented scar
model) using each respective technique was 10.1 ± 2.6 min
(range 5 to 14 minutes) versus 45.8 ± 12.6 min (range 35 to
70 minutes) (p < 0.0001), representing a 4-fold reduction in
image processing time using the CAS approach.
The mean total scar volume obtained using the CAS-
based technique was 11.1 ± 8.2 mL. This showed excellent
correlation to total scar volumes generated by manual ex-
pert segmentation with a correlation coefficient of 0.99
(Figure 4), representative patient examples being shown in
Figure 5. Bland-Altman analysis showed excellent agree-
ment with a non-significant bias of +0.89 mL (95% CI -1.7
to 3.4) (Figure 4). Voxel-based spatial accuracy metrics for
CAS-based scar segmentation were excellent with a Dice
similarly coefficient of 0.71 ± 0.04 and RMSE of 0.72 ±
0.15 mm.
All 14 cases underwent successful fusion of segmented
3D scar to spatially matched 3D MRA datasets. Case exam-
ples of volumetric display are provided in Figure 6.
Intra- and inter-observer reproducibility
Intra-observer reproducibility was excellent [r = 0.98,
bias = -0.2, 95% CI -3.677 to 3.235] with similar inter-
observer reproducibility [r = 0.97, bias = 1.008, 95%
CI -3.914 to 5.929] (Figure 7). No significant difference
in segmentation time was appreciated between the two
users (10.1 ± 2.7 vs. 9.6 ± 2.1, p = 0.76).
Comparison to 2D LGE imaging
To compare 3D scar quantification to conventional
(lower resolution, anisotropic) 2D scar imaging, manual
planimetry of surgical scar on the latter (seen in 12 of 14
datasets, 86%) was performed. Mean segmentation volumes
were then compared to corresponding 3D LGE scar ana-
lysis. As shown in Figure 8A, 2D scar segmentation values
poorly correlated with 3D scar volumes, producing a low
correlation coefficient (r) of 0.2. Intra- and inter-observer
variability of 2D scar quantification was substantially poorer
than for 3D scar quantification (Figure 8B and C).Discussion
This study demonstrates the clinical feasibility of high
resolution volumetric scar imaging in patients with surgi-
cally corrected TOF. The quality of this imaging technique
supports the use of rapid segmentation tools to provide
accurate and reproducible estimates of total scar burden
and to generate volumetric models of scar distribution. As
the former is of current interest in the investigation of risk
prediction, and the latter affords spatial registration of scar
Figure 3 Case examples of high-resolution, isotropic 3D late gadolinium enhancement (LGE) imaging in patients with surgically
corrected Tetralogy of Fallot, presented in representative views using multi-planar reformatting. White arrows: Surgical infundibulotomy
scar. Yellow arrows: Surgical ventricular septal repair scar. Green arrows: Acquired right ventricular insertion site fibrosis.
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may be of clinical value among this population.
CMR is an established and preferred imaging modality
for the assessment of patients with TOF and other con-
genital heart diseases. Its capacity to simultaneously
evaluate cardiac function, 2D and 3D morphology, and
non-invasively quantify hemodynamics without exposure
to ionizing radiation, has made this a commonly per-
formed diagnostic test within this population [7]. While
the use of LGE imaging for evaluations of myocardial
scar may offer incremental value in these patients, sev-
eral challenges exist for its clinical adoption usingFigure 4 Linear regression (left) and Bland-Altman (right) analyses fo
the gold standard of manual segmentation (N = 14). For linear regressio
Bland-Altman analysis the bias is shown with a solid line (95% confidenceconventional techniques [5,8-10]. The native RV tissue is
characteristically thin, only a few millimeters in thick-
ness, and remains so among many patients with early
surgical correction of TOF. Surgical intervention leads
to marked thinning of the free wall as it is replaced by
patch material and surrounding scar. Both native RV tissue
and iatrogenic scar are juxtaposed to pericardial adipose
stores and the posterior sternum. Within the context of
larger and anisotropic voxels, ample opportunity is pro-
vided for partial volume effects to limit the discrimination
of scar signal from adjacent tissue signal on 2D LGE
images. Indeed, no study to date has attempted signal-r accuracy of semi-automated scar segmentation algorithm versus
n analysis, the Pearson correlation coefficient (r) is shown, and for
interval shown by dashed line).
Figure 5 Representative sagittal slices obtained by 3D LGE imaging in two patients (A and B) with Tetralogy of Fallot. Thin-slab, multiplanar
reformatting is shown at the level of the surgical infundibulotomy. Results of manual expert segmentation (red) and semi-automated segmentation
(yellow) are shown below.
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patient population. An incremental contributor to this
challenge is that the architecture of the RVOT is com-
plex and does not maintain co-axial position to any single
imaging plane, exaggerating partial volume influences for
anisotropic 2D techniques. In contrast, the isotropic 3D
imaging technique described provides a 10-fold reduction
in voxel volume and effectively eliminates adjacent fat sig-
nal through application of a fat-saturation pulse. In com-
bination, this significantly improves visualization of surgical
scar (Figure 8) and affords the rapid and reproducible semi-
automated segmentation of myocardial scar in this challen-
ging patient population.
A prognostic role for myocardial scar quantification is
emerging among patients with a variety of cardiomyopathy
states. Numerous studies have recognized that the presence
and volume of myocardial scar predicts the occurrence of
ventricular arrhythmias among patients with ischemic car-
diomyopathy [21-23], dilated cardiomyopathy [22], hyper-
trophic cardiomyopathy [24], and sarcoidosis [25,26]. Two
studies to date have described the use of LGE imaging to
examine the extent of surgical injury in TOF, both beinglimited to a visual-based scoring [5,10]. In a study by Babu-
Naryan et al., adult patients with surgically corrected TOF
received conventional 2D LGE imaging at 1.5 Tesla with
the presence and distribution of surgical scar visually
scored using a standardized RV segmental model. In that
study, the burden of RV scar was associated with greater
New York Heart Association (NYHA)-based symptom bur-
den, reduced maximal exercise capacity (VO2), RV systolic
dysfunction, and elevated atrial natriuretic peptide levels
[5]. Most importantly, RV scar scores were independently
associated with the occurrence of future arrhythmias. In a
subsequent study by Wald et al. the segmental presence of
surgical scar was associated with a reduction in systolic
function of both the RVOT and of the RV globally. These
were in turn associated with a reduction in exercise cap-
acity and an increased prevalence of sustained ventricular
tachycardia [10].
The potential of volumetric scar segmentation models
to be used to guide catheter-based therapies in patients
with adult congenital heart disease is of particular inter-
est. Using the currently described techniques, spatially
accurate 3D myocardial scar models can be generated





























































































Figure 7 Intra-observer (A) and inter-observer (B) variability testing for semi-automated scar quantification. For linear regression analysis (top),
the Pearson correlation coefficient (r) is shown, and for Bland-Altman analysis (bottom) the bias is shown with a solid line (95% confidence interval shown
by dashed line).
Figure 6 Examples of fused 3D MRA/3D scar imaging in patients with surgically corrected Tetralogy of Fallot. Segmented surgical scar
tissue is shown in white.
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Figure 8 Comparison of 2D manual segmentation, and 3D semi-automated segmentation results (left panel, A), and reproducibility of
2D manual segmentation (right). Intra-observer (B) and inter-observer (C) variability testing results for 2D semi-automated scar quantification
are shown. For linear regression analysis (top), the Pearson correlation coefficient (r) is shown, and for Bland-Altman analysis (bottom) the bias is
shown with a solid line (95% confidence interval shown by dashed line).
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aging datasets currently accepted by clinically available
navigation tools. This provides a unique opportunity to
guide catheter-based procedures, such as ventricular
arrhythmia ablation, using substrate-based models – a
new paradigm for invasive arrhythmia therapeutics. Such
methodology is a priority for future work.
Limitations
The study was not designed to evaluate the impact of
RV scar extent on patient symptoms, exercise capacity
or clinical events; endpoints that have been evaluated
within larger studies [5,10]. As a small, single center
feasibility study, we recommend that this technique be
tested by other referral centers, and be evaluated for its
capacity to predict important clinical outcomes. We also
recognize that, due to labor intensity of manual segmenta-
tion, only one expert interpreter performed this task. Ac-
cordingly, reproducibility of the gold standard was not
established.
Comparison of 3D scar quantification with 2D scar quan-
tification herein was primarily undertaken to demonstratethe challenges of RV scar segmentation using conventional
2D LGE images. As optimization of a 2D imaging approach
was not the study’s focus, it is possible that other pathways
towards the improvement of 2D acquisitions could be ex-
plored, such as; reduction in slice thickness, inter-slice gap,
and the application of fat-suppression techniques. However,
all such adaptations may not adequately address a need to
provide imaging data sufficiently robust to allow for semi-
automated scar segmentation, and do not provide
matched MRA data that facilitates rapid image fusion for
anatomic spatial registration.
In this sentinel cohort study we did not identify focal scar
(i.e.: amenable to segmentation) in regions remote to the
primary surgical sites. However, such findings can be ob-
served in this population and are therefore not sufficiently
studied by this pilot study. Segmentation times might also
be affected by the need to capture such regions. Patchy
mid-wall fibrosis of the RV insertion site was not seg-
mented for 2 reasons; i) the clinical relevance of this finding
for the navigation of invasive procedures is uncertain, and
ii) its signal characteristics are unique to that of surgical
scar. The latter highlights a limitation of all current
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lation, in that unique thresholds must be employed for the
capture of disparate fibrosis phenotypes.
Conclusions
High resolution, 3D LGE imaging of myocardial scar in
surgically repaired TOF is clinically feasible and affords
accurate and reproducible estimates of total scar volume
as well as volumetric modeling of scar distribution.
Given growing clinical interest in scar metrics for the
prediction of arrhythmia risk, and minimally invasive
therapies aimed at their treatment, this novel imaging
technique may be well suited as a clinical tool to assist
in the care of this expanding population.
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